Simon Richardson

Dr Richardson is a CRUK Clinician Scientist and Leukaemia UK John Goldman Fellow studying B-cell Acute Lymphoblastic Leukaemia (B-ALL), the commonest cancer in children. Dr Richardson studied Medical Sciences and Pharmacology at the University of Cambridge before completing clinical training at the University of Oxford, where he was awarded the George Pickering Prize for best performance in medical finals. He undertook a PhD at the CRUK UCL Cancer Institute, where he discovered and characterised unique human immune cell progenitors that are a likely origin of childhood B-ALL. His current projects are modelling the disordered epigenetic and stem cell states underlying high-risk B-ALL, alongside using cutting edge functional genomics screening and systems biology to develop novel therapeutic approaches.